Hybrid: Research Ethics & Policy Series (REPS)
Weds. February 14, 2024.  12PM - 1PM EST

Clinical trials require access to limited site-level resources: patients, staff, and infrastructure. Without careful selection between acceptable studies, the most important may be delayed, fail to adequately enroll, or never launch. Prioritization is therefore ethically critical but to date has not received much bioethical attention beyond consideration of how sponsors allocate funding.

This lecture will describe a conceptual ethical framework for site-level trial prioritization and provide insights from a pair of interview studies examining how research institutions decided which COVID-19 studies to pursue during the height of the pandemic and how NCI-funded cancer centers select which oncology protocols will be allowed to proceed.

Location: Hybrid, B102AB Richards Bldg., 3700 Hamilton Walk

Registration Required:  Register REPS Fernandez Lynch

Lunch provided. Streaming available via Zoom.